Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients

Determining the safety of ultrafocal salvage high-dose-rate brachytherapy for radiorecurrent prostate cancer: A toxicity assessment of 150 patients

Background and purpose: Local re-treatment of radiorecurrent prostate cancer is potentially curative. However, the increased risk of severe toxicity may outweigh the opportunity of cancer control. This study aims to evaluate treatment-related toxicity from ultrafocal salvage high-dose-rate brachythe...

Full description

Bibliographic Details
Main Authors: Marieke van Son, M.D., Max Peters, M.D., Ph.D., Marinus Moerland, Ir., Ph.D., Sandrine van de Pol, M.D., Wietse Eppinga, M.D., Jan Lagendijk, Prof., Jochem van der Voort van Zyp, Ass. prof.
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Toxicity
CTCAE 4.0
Prostate cancer
Local recurrence
Focal salvage therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630820301051

Internet

http://www.sciencedirect.com/science/article/pii/S2405630820301051

Similar Items